Characterizing the Use of Ofatumumab in a Real World Setting

NCT05090033 · clinicaltrials.gov ↗

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

OTHER: ofatumumab

Sponsor

Novartis Pharmaceuticals